ComplianceXL

BLOG

Stay informed with the latest regulatory updates
Home / CA Prop 65 makes amendment to NSRL section 25705
Prop65-NSRL

CA Prop 65 makes amendment to NSRL section 25705

Proposition 65 requires businesses to provide a warning label on their products if the product contains any of the following: -Known carcinogens -Chemicals known to cause birth defects or other reproductive harm -Chemicals with a reproductive hazard label.

The purpose of this amendment is to require that NSRLs include warnings for substances that are known to the state of California to cause cancer or reproductive toxicity.

On 6 Jul 2021, the Office of Administrative Law Amended NSRL (No Significant Risk Level) for below 3 chemicals to section 25705. From Oct 1, 2021, the regulation will be effective.

  • Dibromoacetic Acid- (CAS No.-631-64-1)- establishes a No Significant Risk Level of 2.8 micrograms per day, with regards to Prop 65
  • Dichloroacetic Acid – (CAS No.-79-43-6) – establishes a No Significant Risk Level of 17 micrograms per day, with regards to Prop 65
  • Trichloroacetic Acid – (CAS No. – 76-03-9) – establishes a No Significant Risk Level of 9.9 micrograms per day, with regards to Prop 65

The current Prop 65 list has more than 1000 chemicals listed. It has chemicals that are known to cause cancer, birth defects or reproductive toxicity.

This amendment amends Section 25705 of the NSRL to provide that the exemption from listing or providing a Proposition 65 warning for chemicals that are listed as carcinogens on the basis of their animal dosing dossiers will apply only to those dossiers containing coefficients of absorption (CAs) less than or equal to 0.02.

Talk to an Expert

Connect with our experts for tailored advice on achieving supply chain compliance and sustainability. Start your journey to compliance excellence now.

By clicking on send, you agree to our Terms of Use and Privacy Policy

Talk to an Expert

Connect with our experts for tailored advice on achieving supply chain compliance and sustainability. Start your journey to compliance excellence now.

By clicking on send, you agree to our Terms of Use and Privacy Policy

Download Case study

Thank You!

The PDF has been downloaded successfully.
By clicking on send, you agree to our Terms of Use and Privacy Policy